0

524322

KABRADG

img img img img
No Data Available

KABRA DRUGS LTD. Share Price Update

As of the latest trading session, KABRA DRUGS LTD. share price is currently at ₹34.67, which is up by ₹0.91 from its previous closing. Today, the stock has fluctuated between ₹34.17 and ₹35.43. Over the past year, KABRA DRUGS LTD. has achieved a return of 219.60%. In the last month alone, the return has been 20.32%.

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

KABRA DRUGS LTD. fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    82.20

  • P/E Ratio (TTM)

    67.50

  • Beta

    0.53

  • Book Value / share

    10.96

  • Return on equity

    0.00%

  • EPS (TTM)

    0.50

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    2.57

info icon alternate text

KABRA DRUGS LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2025 (Values in Cr)
Revenue 30.42
Operating Expense 28.00
Net Profit 2.57
Net Profit Margin (%) 8.44
Earnings Per Share (EPS) 1.08
EBITDA 2.61
Effective Tax Rate (%) 1.15
Particulars SEP 2025 (Values in Cr)
Revenue 19.76
Operating Expense 17.74
Net Profit 1.84
Net Profit Margin (%) 9.31
Earnings Per Share (EPS) 0.77
EBITDA 2.21
Effective Tax Rate (%) 16.74
Particulars JUN 2025 (Values in Cr)
Revenue 7.15
Operating Expense 7.67
Net Profit -0.50
Net Profit Margin (%) -6.99
Earnings Per Share (EPS) -0.21
EBITDA -0.50
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.25
Net Profit 0.39
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.21
EBITDA 0.40
Effective Tax Rate (%) 0.00
Particulars DEC 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.54
Net Profit -0.54
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.53
EBITDA -0.54
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.00
Operating Expense 1.73
Net Profit -1.09
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.99
EBITDA -1.08
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.74
Net Profit -0.74
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -1.68
EBITDA -0.74
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.34
Net Profit -0.34
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.77
EBITDA -0.34
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 0.00
Operating Expense 0.19
Net Profit -0.19
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.42
EBITDA -0.18
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 0.00
Operating Expense 0.18
Net Profit -0.18
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.41
EBITDA -0.15
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 10.40
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.08
EBITDA Margin 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share -3.34
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 8.83
EBITDA Margin 0.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share -1.67
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share -0.90
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share -0.47
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 21.29
Total Assets 25.22
Total Liabilities 25.22
Total Equity 24.65
Share Outstanding 2
Price to Book Ratio 1.07
Return on Assets (%) -4.30
Return on Capital (%) -4.33
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.67
Total Assets 4.57
Total Liabilities 4.57
Total Equity 1.08
Share Outstanding 0
Price to Book Ratio -2.15
Return on Assets (%) -16.10
Return on Capital (%) -26.37
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 0.70
Total Liabilities 0.70
Total Equity -0.73
Share Outstanding 0
Price to Book Ratio -3.34
Return on Assets (%) -48.02
Return on Capital (%) -51.92
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 0.72
Total Liabilities 0.72
Total Equity -0.39
Share Outstanding 0
Price to Book Ratio -5.06
Return on Assets (%) -25.40
Return on Capital (%) -29.3
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 1.40
Total Liabilities 1.40
Total Equity -0.20
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) -12.83
Return on Capital (%) -25.99
Particulars MAR 2025 (Values in Cr)
Net Income -1.08
Cash from Operations -4.70
Cash from Investing -0.05
Cash from Financing 23.38
Net change in Cash 18.62
Free Cash Flow -4.65
Particulars MAR 2024 (Values in Cr)
Net Income -0.73
Cash from Operations -0.20
Cash from Investing 0.00
Cash from Financing 2.87
Net change in Cash 2.66
Free Cash Flow -0.20
Particulars MAR 2023 (Values in Cr)
Net Income -0.33
Cash from Operations -0.35
Cash from Investing 0.00
Cash from Financing 0.35
Net change in Cash 0.00
Free Cash Flow -0.35
Particulars MAR 2022 (Values in Cr)
Net Income -0.18
Cash from Operations -0.13
Cash from Investing 0.00
Cash from Financing 0.12
Net change in Cash 0.00
Free Cash Flow -0.13
Particulars MAR 2021 (Values in Cr)
Net Income -0.18
Cash from Operations -0.24
Cash from Investing 0.00
Cash from Financing 0.24
Net change in Cash 0.00
Free Cash Flow -0.24
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 28.58 12.37 1.48 219.02 23.12 / 52.00
BLISS GVS PHARMA LTD 217.80 20.82 2.03 2304.08 105.05 / 225.00
CIPLA LTD 1330.85 22.61 3.26 107503.49 1283.00 / 1672.20
FERMENTA BIOTECH LIMITED 310.90 10.34 2.34 915.01 219.00 / 399.00
GLAXOSMITHKLINE PHARMA LT 2593.90 43.69 25.73 43942.23 1968.00 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 28.58 23.24 3.98 219.02 23.12 / 52.00
AMRUTAJAN HEALTH LTD 632.15 31.61 5.34 1827.59 548.05 / 789.95
ASTRAZENECA PHARMA IND LT 8878.75 106.70 27.78 22196.88 6501.60 / 10653.05
BLISS GVS PHARMA LTD 217.80 29.67 2.08 2304.08 105.05 / 225.00

KABRA DRUGS LTD. shareholding pattern

Holding

100.0%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

KABRA DRUGS LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
34.67 2.72 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 33.10
  • 26 Days 30.30
  • 10 Days 32.00
  • 50 Days 28.80
  • 12 Days 31.60
  • 100 Days 26.00
  • 20 Days 30.70
  • 200 Days 21.40
33.70 PIVOT

First Support

32.60

First Resistance

34.85

Second Support

31.45

Second Resistance

35.95

Third Support

30.35

Third Resistance

37.10

RSI

70.34

ADX

18.63

MACD

1.37

Williams % R

-21.25

Commodity Channel Index (CCI)

142.88

Date

2026-02-13

Week

205785.00

Same Day

130162.00

Month

119513.00

1 Year

0.53

3 Year

0.15

Over 1 Month

20.32%

down

Over 1 Year

219.60%

down

Over 3 Months

55.38%

down

Over 3 Years

82.30%

down

Over 6 Months

67.16%

down

Over 5 Years

48.08%

down

KABRA DRUGS LTD. Corporate Actions

Top Gainers

KABRA DRUGS LTD. Share Price

Kabra Drugs Ltd was incorporated as a Limited Company on August 22, 1989. The Company has set up a Unit at Indore for manufacturing of Ether derivatives which includes Diethyl Ether (Anesthesia), Solvent Ether, Ethyl Chloride Spray (General Anesthesia) and Surgical. The commercial production commenced in 1991. Kabra Drugs Limited is the only manufacturer of Ether derivatives in the State of M.P. tHE Company is presently engaged in the business of Permaculture manufacturing and trading in pharma related products.

The latest addition to the product line is the range of disinfectants which includes hand wash gel, hand sanitizer and antimicrobial gel. In India there are very few manufacturers who are manufacturing the said products. The company is the sole manufacturer of antimicrobial hand wash gel and other disinfectant products in India. The company is also a registered supplier to the Ministry of Defence.

With manufacturing and regular supply in the domestic market for injectables, soft gelatin capsules and liquids (oral and external especially alcohol products) the company now looks at the global market. A number of new products have been developed for the same.

Kabra Drugs are known to meet the diverse medical needs of patients in Emerging Markets in an innovative, socially responsible and commercially viable manner. Their products are manufactured at state of the art ultra modern plants with latest equipments backed by professional technocrats. These are WHO-GMP, cGMP & Schedule 'M' approved facilities which also helps to get business approvals for Government, Semi- Government under takings , big institutions and other N.G.O's. Besides, they are also actively involved in trading and marketing of biological API's and Biochemicals.

Due to scarcity of working capital funds, the Company is not able to perform any business activities. To make the Company operational, the Board is making its best effort to implement the cost reduction measures to the extent feasible. Several cost cutting measures have already been undertaken by the Company.

Parent organization Indian Private
NSE symbol [-]
Founded 1989
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Kabra Drugs Ltd?

Answer Field

Kabra Drugs Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 34.67 as on Feb 16 2026 03:30 PM.

What is the Market Cap of Kabra Drugs Ltd Share?

Answer Field

The market cap of Kabra Drugs Ltd for NSE ₹ 0.00 & for BSE ₹ 82.20 as on Feb 16 2026 03:30 PM.

What is the 52 Week High and Low of Kabra Drugs Ltd?

Answer Field

The 52 Week High and Low of Kabra Drugs Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 35.52 and ₹ 10.56.

What is 1 year return for Kabra Drugs Ltd?

Answer Field

The 1 year returns on the stock has been 219.60%.

What is the P/E Ratio of Kabra Drugs Ltd Share?

Answer Field

As on Feb 16 2026 03:30 PM the price-to-earnings (PE) ratio for Kabra Drugs Ltd share is 67.50.

What is the PB ratio of Kabra Drugs Ltd Share?

Answer Field

As on Feb 16 2026 03:30 PM, the price-to-book (PB) ratio for Kabra Drugs Ltd share is 10.96.

How to Buy Kabra Drugs Ltd Share?

Answer Field

You can trade in Kabra Drugs Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Kabra Drugs Ltd Share on Bajaj Broking App?

Answer Field

To buy Kabra Drugs Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Kabra Drugs Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59